A1BI1

{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}(cyclopropyl)methanone

Created:	2024-12-02
Last modified:	2025-08-13

Find Related PDB Entry
1 entries where A1BI1 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	1
Bond Count	65
Aromatic Bond Count	22

2D diagram of A1BI1

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}(cyclopropyl)methanone
Systematic Name (OpenEye OEToolkits)	[(3~{R})-3-[4-azanyl-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-cyclopropyl-methanone
Formula	C₂₆ H₂₆ N₆ O₂
Molecular Weight	454.524
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	O=C(C1CC1)N1CCCC(C1)n1nc(c2c(N)ncnc21)c1ccc(Oc2ccccc2)cc1
SMILES	CACTVS	3.385	Nc1ncnc2n(nc(c3ccc(Oc4ccccc4)cc3)c12)[CH]5CCCN(C5)C(=O)C6CC6
SMILES	OpenEye OEToolkits	3.1.0.0	c1ccc(cc1)Oc2ccc(cc2)c3c4c(ncnc4n(n3)C5CCCN(C5)C(=O)C6CC6)N
Canonical SMILES	CACTVS	3.385	Nc1ncnc2n(nc(c3ccc(Oc4ccccc4)cc3)c12)[C@@H]5CCCN(C5)C(=O)C6CC6
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	c1ccc(cc1)Oc2ccc(cc2)c3c4c(ncnc4n(n3)[C@@H]5CCCN(C5)C(=O)C6CC6)N
InChI	InChI	1.06	InChI=1S/C26H26N6O2/c27-24-22-23(17-10-12-21(13-11-17)34-20-6-2-1-3-7-20)30-32(25(22)29-16-28-24)19-5-4-14-31(15-19)26(33)18-8-9-18/h1-3,6-7,10-13,16,18-19H,4-5,8-9,14-15H2,(H2,27,28,29)/t19-/m1/s1
InChIKey	InChI	1.06	GMAYFNOHSBTWNT-LJQANCHMSA-N

Related Resource References

Resource Name	Reference
PubChem	122432650
ChEMBL	CHEMBL3746490

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.